OA05.05 Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
Fabrice Barlesi,Johan Vansteenkiste,David R. Spigel,Hidenobu Ishii,Marina Chiara Garassino,F. De Marinis,Mustafa Ozguroglu,Aleksandra Szczesna,Andreas Polychronis,Ruchan Uslu,Maciej Krzakowski,Jin Soo Lee,Luana Calabrò,Osvaldo Arén Frontera, B. Ellers-Lenz,Marcis Bajars,Mary Ruisi, K. Park JOURNAL OF THORACIC ONCOLOGY（2018）
关键词
Phase 3,avelumab,docetaxel
AI 理解论文
溯源树
样例
